Tipp

Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges 

Zeitschrift:: Wiener Medizinische Wochenschrift > Ausgabe 15-16/2013

Autoren:: MD Claudio Guarneri, MD, PhD Valentina Bevelacqua, MD, PhD Kristina Semkova, MD, PhD Georgi Tchernev, Dipl.-Med Sven Tempel, MD Uwe Wollina

Summary

Acral lentiginous melanoma (ALM) is an uncommon melanoma type among Caucasions. ALM bears an unfavorable prognosis because of late presentation or common misdiagnosis. Amelanotic variants, albeit rare, may pose an additional clinical challenge and may further delay the diagnosis and treatment. Thus, the threshold for biopsying even marginally suspicious lesions should be low. We present two cases of Caucasian patients with amelanotic subungual ALM, stage 2a and 2c respectively, successfully treated with a functional amputation.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Jetzt einloggen Kostenlos registrieren

Ridgeway C, Hieken T, Ronan S, et al. Acral lentiginous melanoma. Arch Surg. 1995;130:88–92. PubMedCrossRef

Finlay RK III, Driscoll DL, Blumenson LE, Karakousis CP. Subungual melanoma: an eighteen-year review. Surgery. 1994;116:96–100.

Wouters LT, Thissen MR. The acrolentiginous melanoma: how to recognize and when to refer?. Ned Tijdschr Geneeskd. 2012;156(34):A4927. PubMed

Koch SE, Lange JR. Amelanotic melanoma: the great masquerader. J Am Acad Dermatol. 2000;45:731–4. CrossRef

Banfield CC, Redburn JC, Dawber RPR. The incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regions. Br J Dermatol. 1998;139:276–9. PubMedCrossRef

Kato T, Suetake T, Sugiyama Y, Tabata N, Tagami H. Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol. 1996;134:383–7. PubMedCrossRef

Sureda N, Phan A, Poulalhon N, Balme B, Dalle S, Thomas L. Conservative surgical management of subungual (matrix derived) melanoma: report of seven cases and literature review. Br J Dermatol. 2011;165:852–8. PubMedCrossRef

Haneke E. Ungual melanoma—controversies in diagnosis and treatment. Dermatol Ther. 2012;25:510–24. PubMedCrossRef

Rex J, Paradelo C, Mangas C, Hilari JM, Fernandez-Figueras MT, Ferrandiz C. Management of primary cutaneous malignant melanoma of the hands and feet: a clinicoprognostic study. Dermatol Surg. 2009;35:1505–13. PubMedCrossRef

Titel: Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges 
Autoren:: MD Claudio Guarneri
MD, PhD Valentina Bevelacqua
MD, PhD Kristina Semkova
MD, PhD Georgi Tchernev
Dipl.-Med Sven Tempel
MD Uwe Wollina
Publikationsdatum: 01.08.2013
DOI: https://doi.org/10.1007/s10354-013-0194-4
Verlag: Springer Vienna
Zeitschrift: Wiener Medizinische Wochenschrift
Ausgabe 15-16/2013
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 15-16/2013

Cutaneous side effects of vemurafenib: a case report and discussion

Cetuximab for treatment of advanced squamous cell carcinoma in solid organ transplant recipients

Skin cancer treatment options: new horizons and promises for the future

Atypical fibroxanthoma—a diagnosis of exclusion!

Advanced basal cell carcinoma

Merkelzellkarzinom: eine Überprüfung und Aktualisierung über die Pathogenese, Diagnose und Therapieansätze